FRONTEO Inc.
Director / AI Solution Business Management and President's Office Manager
Mari Yamamoto

After joining an advertising agency, she was enrolled in a risk management company.Launch the mental health care business, execute business plans, product development, marketing, and sales strategies, and lead to the top market share in the industry. In 2014, she became a director of the company and was listed on the First Section of the Tokyo Stock Exchange in 2017.
Joined FRONTEO Inc. in December 2018 and became a director in 12, managing and directing the entire AI solution business.
In the life science AI business, we will promote development in the digital health field such as diagnostic support and disease prediction using the artificial intelligence engine "Concept Encoder", and also in the drug discovery field, a drug discovery support AI system that supports speeding up the discovery of candidate compounds. To challenge new areas in life science.
In the business intelligence business, he uses the artificial intelligence engine "KIBIT" to direct the DX promotion of companies.We will also develop solutions that utilize AI in the field of economic security to support governments, government agencies, and companies.

 

Obtained a Ph.D. (Science) through physics research.He is engaged in the fusion of condensed matter physics research and experiments and data analysis at universities and UK science and technology facilities.He has produced 70 English papers, 5 Japanese articles, 7 invited lectures (including 5 international conferences), and more than 100 presentations at academic conferences and research groups.In his current position, he researches and develops the algorithm of the artificial intelligence KIBIT, and has succeeded in major innovation.Currently, he is leading the improvement and creation of further algorithms, the design of KIBIT-equipped products, and business reforms.